Skip to content
Clinical Trials – home
PolandBack to Poland

Clinical trials in Osielsko – page 8

917 clinical trials in Osielsko, Poland across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

PolandOur site in PolandBadaniaKliniczne.pl(opens in a new tab)
Osielsko at a glance
917
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

917 trials in Osielsko

Open in trial search

Crohn's disease

Recruiting

Study on the Effects of MORF-057 for Adults with Moderate to Severe Crohn's Disease

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:MORF-057
  • Sponsor:Morphic Therapeutic Inc.

Study on Long-term Safety of Nivolumab and Drug Combination for Cancer Patients from Previous BMS Trials

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company

Crohn's disease

Recruiting

Study on the Effects of Zasocitinib for Patients with Moderate to Severe Crohn's Disease

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Zasocitinib
  • Sponsor:Takeda Development Center Americas Inc.

Alcoholism

Recruiting

Study on Sodium Oxybate for Reducing Alcohol Consumption in Patients with Alcohol Addiction

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Sodium Oxybate
  • Sponsor:Laboratorio Farmaceutico C.T. S.r.l.

Study on Cytisine for Quitting Nicotine E-Cigarettes and Tobacco in Motivated Individuals

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Cytisinicline
  • Sponsor:University of Rzeszow

Study on the Effectiveness and Safety of Deucravacitinib for Adults with Active Sjogren's Syndrome

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Deucravacitinib
  • Sponsor:Bristol-Myers Squibb Services Unlimited Company

Study on the Long-term Safety and Efficacy of Pembrolizumab and Lenvatinib for Patients with Advanced Tumors

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Favezelimab
  • Sponsor:Merck Sharp & Dohme LLC

Study on the Safety and Effectiveness of Dazucorilant for Patients with Amyotrophic Lateral Sclerosis (ALS)

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Dazucorilant
  • Sponsor:Corcept Therapeutics Inc.

Efficacy and Safety of Three Different Doses of Pirtobrutinib in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Who Previously Received BTK Inhibitor Treatment

InvestigationalNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Pirtobrutinib
  • Sponsor:Eli Lilly & Co.

Efficacy and Safety of RO7568282 in Adults with Early Symptomatic Alzheimer’s Disease

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Sponsor:F. Hoffmann-La Roche AG

A Phase II Randomized, Double‑Blind Study of RO7568282 for Safety and Efficacy in Early‑Stage Parkinson’s Disease Patients

Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Sponsor:F. Hoffmann-La Roche AG

Comparison of rocbrutinib versus pirtobrutinib in patients with relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Pirtobrutinib
  • Sponsor:Newave Pharmaceutical Inc.

Other cities in Poland

The busiest research cities in the country

All 236 cities in Poland

Clinical research in Osielsko

What the registry says about research in the country

01 Psoriasis Research

Comprehensive clinical trials focusing on moderate to severe plaque psoriasis, including studies evaluating new therapeutic approaches for patients with special area involvement.

  • Treatment evaluation for special areas
  • Long-term safety assessments
  • Novel therapeutic compounds

Multiple innovative treatments being tested to improve patient outcomes and quality of life.

02 Vitiligo Studies

Advanced research into nonsegmental vitiligo treatments, exploring both oral medications and systemic therapies for long-term management.

  • Efficacy trials for new medications
  • Long-term safety evaluations
  • Adult and adolescent treatments

Focused on developing sustainable treatment options for vitiligo patients.

03 Dermatological Conditions

Investigating treatments for various skin conditions including chronic hand eczema and alopecia areata.

  • Atopic hand eczema therapies
  • Severe alopecia treatments
  • Safety and tolerability studies

Comprehensive research aimed at addressing challenging dermatological conditions.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.